GE Healthcare Enters Homecare Segment With Strategic Investment in Pulsenmore, Aims to Increase Peace of Mind for Expectant Mothers and Reduce In-Person Visits
Retrieved on:
Thursday, May 12, 2022
Medical Devices, Women, FDA, Baby, Maternity, Biotechnology, Radiology, Health, Consumer, General Health, Smartphone, Physician, API, Software, Thomas Edison, ESRD, Primary care, IVF, Insight, Chronic kidney disease, Patient, Woman, News, Health, TASE, Decision-making, Pregnancy, HMO, Clalit Health Services, USD, Marketing, Tel Aviv Stock Exchange, National Association Medical Staff Services, FDA, U.S. FDA, Partnership, Instagram, Ecosystem, Empowerment, Adoption, Pit additive, GE Healthcare, Texas Homecare, LinkedIn, Twitter, CAGR, Healthcare Facilities Accreditation Program, CHF, Heart, Refugee, NYSE, Pharmaceutical industry, Medical imaging, Online shopping, Facebook
This investment is aimed at accelerating global adoption of Pulsenmores homecare ultrasound solutions and will also support their goal to pursue U.S. FDA clearance and commercial expansion.
Key Points:
- This investment is aimed at accelerating global adoption of Pulsenmores homecare ultrasound solutions and will also support their goal to pursue U.S. FDA clearance and commercial expansion.
- Pulsenmore CEO and founder Dr. Elazar Sonnenschein said, Our agreement with GE Healthcare is a resounding vote of confidence in our ultrasound technology and our company.
- We also recognize the desire of patientsin this case, pregnant womento be more empowered and involved in their healthcare.
- GE Healthcare is the $17.7 billion healthcare business of GE (NYSE: GE).